Secreted frizzled-related protein 1 regulates adipose tissue expansion and is dysregulated in severe obesity.
Secreted frizzled-related protein 1 regulates adipose tissue expansion and is dysregulated in severe obesity.
复制标题
DOI:
10.1038/ijo.2010.107
复制
发表时间:
2010-12
影响因子:
4.9
通讯作者:
Vidal-Puig, A.
中科院分区:
文献类型:
--
作者:
Lagathu, C.;Christodoulides, C.;Tan, C. Y.;Virtue, S.;Laudes, M.;Campbell, M.;Ishikawa, K.;Ortega, F.;Tinahones, F. J.;Fernandez-Real, J-M;Oresic, M.;Sethi, J. K.;Vidal-Puig, A.
The Wnt/β-catenin signalling network offers potential targets to diagnose and uncouple obesity from its metabolic complications. Here we investigate the role of the Wnt antagonist, secreted Frizzled related protein 1 (SFRP1) in promoting adipogenesis in vitro and adipose tissue expansion in vivo. We use a combination of human and murine, in vivo and in vitro models of adipogenesis, adipose tissue expansion and obesity-related metabolic syndrome to profile the involvement of SFRP1. Secreted Frizzled related protein 1 (SFRP1) is expressed in both murine and human mature adipocytes. The expression of SFRP1 is induced during in vitro adipogenesis and SFRP1 is preferentially expressed in mature adipocytes in human adipose tissue. Constitutive ectopic expression of SFRP1 is proadipogenic and inhibits the Wnt/β-catenin signalling pathway. In vivo endogenous levels of adipose SFRP1 are regulated in line with proadipogenic states. However, in longitudinal studies of high fat diet-fed mice we observed a dynamic temporal but biphasic regulation of endogenous SFRP1. In agreement with this profile we observed that SFRP1 expression in human tissues peaks in patients with mild obesity and gradually falls in morbidly obese subjects. Our results suggest that SFRP1 is an endogenous modulator of Wnt/β-catenin signalling and participates in the paracrine regulation of human adipogenesis. The reduced adipose expression of SFRP1 in morbid obesity and its knock-on effect to prevent further adipose tissue expansion may contribute to the development of metabolic complications in these individuals.
登录
查看更多内容
DOI:
10.1074/jbc.m310240200
发表时间:
2004-03-19
期刊:
The Journal of biological chemistry
影响因子:
--
作者:
Laudes M;Christodoulides C;Sewter C;Rochford JJ;Considine RV;Sethi JK;Vidal-Puig A;O'Rahilly S
通讯作者:
O'Rahilly S
影响因子:
10.9
作者:
Christodoulides, Constantinos;Lagathu, Claire;Sethi, Jaswinder K.;Vidal-Puig, Antonio
通讯作者:
Vidal-Puig, Antonio
DOI:
10.1016/j.bbrc.2004.03.152
发表时间:
2004-05-14
影响因子:
3.1
作者:
Yang, XL;Jansson, PA;Smith, U
通讯作者:
Smith, U
影响因子:
7.7
作者:
Lagathu, Claire;Christodoulides, Constantinos;Virtue, Sam;Cawthorn, William P.;Franzin, Chiara;Kimber, Wendy A.;Nora, Edoardo Dalla;Campbell, Mark;Medina-Gomez, Gema;Cheyette, Benjamin N. R.;Vidal-Puig, Antonio J.;Sethi, Jaswinder K.
通讯作者:
Sethi, Jaswinder K.
影响因子:
9.8
作者:
Virtue S;Vidal-Puig A
通讯作者:
Vidal-Puig A